Interleukin 12 is a primary cytokine responding to influenza virus infection in the respiratory tract of mice

Acta Virologica

Volumn 53, Issue 4, 2009, Pages 233-240

  Hama, Y ^a   Kurokawa, M ^b   Imakita, M ^c   Yoshida, Y ^a   Shimizu, T ^b   Watanabe, W ^b   Shiraki, K ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^c Department of Cardiology   (Japan)

Author keywords

Cytokines; Influenza A virus; Interleukin 12; Macrophages; Mice; Pneumonia

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIGEN; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNITY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLUENZA; INFLUENZA VIRUS A; LUNG LAVAGE; MACROPHAGE; MOUSE; NONHUMAN; RESPIRATORY SYSTEM; VIRUS TITRATION; ANIMAL; CYTOLOGY; DBA MOUSE; GENETICS; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; LUNG; METABOLISM; MONONUCLEAR CELL; ORTHOMYXOVIRUS INFECTION; PATHOGENICITY; VIROLOGY; VIRUS PNEUMONIA;

INFLUENZA A VIRUS; MUS; ORTHOMYXOVIRIDAE;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; FEMALE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; LUNG; MACROPHAGES; MICE; MICE, INBRED DBA; ORTHOMYXOVIRIDAE INFECTIONS; PNEUMONIA, VIRAL; RNA, MESSENGER;

EID: 77449118445     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: 10.4149/av_2009_04_233     Document Type: Article

References (29)

1. Braun MC, Wang JM, Lahey E, Rabin RL, Kelsall BL (2001): Activation of the formyl peptide receptor by the HIV-derived peptide T-20 suppresses interleukin-12 p70 production by human monocytes. Blood 97, 3531-3536. doi:10.1182/blood.V97.11.3531
2. Cameron LA, Taha RA, Tsicopoulos A, Kurimoto M, Olivenstein R, Wallaert B, Minshall EM, Hamid QA (1999): Airway epithelium expresses interleukin-18. Eur. Respir. J. 14, 553-559. doi:10.1034/j.1399-3003.1999.14c12.x
3. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, Shortridge KF, Gordon S, Guan Y, Peiris JS (2002): Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 360, 1831-1837. doi:10.1016/S0140-6736(02)11772-7
4. D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M, Chan SH, Kobayashi M, Young D, Nickbarg E (1992): Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176, 1387-1398. doi:10.1084/jem.176.5.1387
5. Fukuda Y, Yamamura J, Uwano T, Nishijo H, Kurokawa M, Fukuda M, Ono T, Shiraki K (2003): Regulated transgene delivery by ganciclovir in the brain without physiological alterations by a live attenuated herpes simplex virus vector. Neurosci. Res. 45, 233-241. doi:10.1016/S0168-0102(02)00235-3
6. Furuta Y, Takahashi K, Fukuda Y, Kuno M, Kamiyama T, Kozaki K, Nomura N, Egawa H, Minami S, Watanabe Y, Narita H, Shiraki K (2002): In vitro and in vivo activities of anti-influenza viral compound T-705. Antimicrob. Agents Chemother. 46, 977-981. doi:10.1128/AAC.46.4.977-981.2002
7. Hayden FG, Fritz RS, Lobo MC, Alvord WG, Strober W, Straus S (1998): Local and systemic cytokine responses during experimental human influenza A virus infection: relation to symptom formation and host defense. J. Clin. Invest. 101, 643-649. doi:10.1172/JCI1355
8. Hennet T, Ziltener HJ, Frei K, Peterhans E (1992): A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J. Immunol. 149, 932-939.
9. Imakita M, Shiraki K, Yutani C, Ishibashi-Ueda H (2000): Pneumonia caused by rhinovirus. Clin. Infect. Dis. 30, 611-612. doi:10.1086/313723
10. Kaiser L, Fritz RS, Straus SE, Gubareva L, Havden FG (2001): Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J. Med. Virol. 64, 262-268. doi:10.1002/jmv.1045
11. Kamiyama H, Kurimoto M, Yamamura J, Uwano T, Hirashima Y, Kurokawa M, Endo S, Shiraki K (2001): Effect of immunity on gene delivery into anterior horn motor neurons by live attenuated herpes simplex virus vector. Gene Therapy 8, 1180-1187. doi:10.1038/sj.gt.3301503 (Pubitemid 32776392)
12. Karp CL, Wysocka M, Wahl LM, Ahearn JM, Cuomo PJ, Sherry B, Trinchieri G, Griffin DE (1996): Mechanism of suppression of cell-mediated immunity by measles virus. Science 273, 228-231. doi:10.1126/science.273.5272.228 (Pubitemid 26285887)
13. Kashiwamura S, Ueda H, Okamura H (2002): Roles of interleukin-18 in tissue destruction and compensatory reactions. J. Immunother. 25, S4-11. doi:10.1097/00002371-200203001-00002
14. Kurokawa M, Brown J, Kagawa Y, Shiraki K (2003): Cytokine-regulatory activity and therapeutic efficacy of cynnamyl derivatives in endotoxin shock. Eur. J. Pharm. 474, 283-293. doi:10.1016/S0014-2999(03)02036-3
15. Kurokawa M, Imakita M, Kumeda C., Shiraki K (1996a): Cascade of fever production in mice infected with influenza virus. J. Med. Virol. 50, 152-158. doi:10.1002/(SICI)1096-9071(199610)50:2〈152::AID-JMV8〉3.0.CO;2-9
16. Kurokawa M, Imakita M, Kumeda CA, Yukawa TA, Shiraki K (1996b): Kakkon-to suppressed interleukin-1 production responsive to interferon and alleviated influenza infection in mice. J. Tradit. Med. 13, 201-209.
17. Kurokawa M, Kumeda CA, Yamamura J, Kamiyama J, Shiraki K (1998): Antipyretic activity of cinnamyl and related compounds in Kakkon-to, a traditional medicine, in influenza virus-infected mice. Eur. J. Pharmacol. 348, 45-51. doi:10.1016/S0014-2999(98)00121-6
18. Kurokawa M, Tsurita M, Brown J, Fukuda Y, Shiraki K (2002): Effect of interleukin-12 level augmented by Kakkon-to, a herbal medicine, in the early stage of influenza infection on its alleviation. Antiviral Res. 56, 183-188. doi:10.1016/S0166-3542(02)00104-3 (Pubitemid 35279666)
19. Liu B, Mori I, Ossain HMJ, Dong L, Takeda K, Kimura Y (2004): Interleukin-18 improves the early defense system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity. J. Gen. Virol. 85, 423-428. doi:10.1099/vir.0.19596-0
20. Locksley RM, Killeen N, Lenardo MJ (2001): The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104, 487-501. doi:10.1016/S0092-8674(01)00237-9 (Pubitemid 32201945)
21. Monteiro JM, Harvey C, Trinchieri G (1998): Role of interleukin-12 primary influenza virus infection. J. Virol. 72, 4825-4831. (Pubitemid 28215659)
22. Neff-LaFord HD, Vorderstrasse BA, Lawrence BP, Fewer BP (2003): CTL, not enhanced NK cells, are sufficient for viral clearance from the lungs of immunocompromised mice. Cell Immunol. 226, 54-64. doi:10.1016/j.cellimm.2003.11. 005
23. Pirhonen J, Matikainen S, Julkunen I (2002): Regulation of virus-induced IL-12 and IL-23 expression in human macrophages. J. Immunol. 169, 5673-5678. (Pubitemid 35291668)
24. Pirhonen J, Sareneva T, Julkunen I, Matikainen S (2001): Virus infection induces proteolytic processing of IL-18 in human macrophages via caspase-1 and caspase-3 activation. Eur. J. Immunol. 31, 726-730. doi:10.1002/1521- 4141(200103)31:3〈726::AID-IMMU726〉3.0.CO;2-5
25. Seo SH, Hoffmann E, Webster RG (2002): Lethal H5N1influenza viruses escape host anti-viral cytokine responses. Nature Med. 8, 950-954. doi:10.1038/nm757 (Pubitemid 35033698)
26. Seo SH, Webster RG (2002): Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells. J. Virol. 76, 1071-1076.
27. Szretter KJ, Gangappa S, Lu X, Smith C, Shieh W-J, Zaki S, Sambhara S, Tumpey TM, Katz JM (2007): Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J. Virol. 81, 2736-2744. doi:10.1128/JVI.02336-06 (Pubitemid 46447038)
28. Tsurita M, Kurokawa M, Imakita M, Fukuda Y, Watanabe Y, Shiraki K (2001): Alleviation of influenza infection by early augmentation of interleukin (IL)-12 level in the airway of mice administered orally with clarithromycin or intranasally with IL-12. J. Pharmacol. Exp. Therapeut. 298 362-368.
29. Van Reeth K (2000): Cytokines in the pathogenesis of influenza. Vet. Microbiol. 74, 109-116. doi:10.1016/S0378-1135(00)00171-1